ACE Report Cover
TKA: No effect of fibrin sealant on reducing blood loss and functional recovery
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Idioma
Download Download Download
Descarregar
Cite this Report Cite this Report Cite this Report
Citar
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoritos
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Idioma
Download Download Download
Descarregar
Cite this Report Cite this Report Cite this Report
Citar
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoritos
ARTHROPLASTY
TKA: No effect of fibrin sealant on reducing blood loss and functional recovery .

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2013;1(8):6 Acta Orthop. 2013 Apr;84(2):153-8. doi: 10.3109/17453674.2013.769082. Epub 2013 Jan 25

24 patients (48 knees) undergoing simultaneous bilateral total knee arthroplasty (TKA) had their knees 1:1 randomized to receive an intraoperative application of either fibrin sealant or saline. The purpose was to determine the adjuvant effect of fibrin sealant on postoperative blood loss in patients already treated with preoperative tranexamic acid and tourniquet use. Blood loss was calculated 24 hours following surgery, and patients were assessed for functional recovery up to 21 days postoperatively. The findings indicated that there was no decrease in blood loss in knees treated with fibrin sealant, and that pain, swelling, range of motion, and isokinetic strength was similar between knees, regardless of the application of fibrin sealant or saline.


Detalhes do financiamento da publicação +
Financiamento:
Industry funded
Patrocinador:
Johnson and Johnson Medical Ltd.
Conflicts:
None disclosed

Risco de viés

8,5/10

Critérios de notificação

17/20

Índice de Fragilidade

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Sim = 1

Incerto = 0,5

Não relevante = 0

Não = 0

A Avaliação dos Critérios de Relato avalia a transparência com que os autores relatam as caraterísticas metodológicas e do ensaio na publicação. A avaliação está dividida em cinco categorias que são apresentadas de seguida.

4/4

Randomization

3/4

Outcome Measurements

2/4

Inclusion / Exclusion

4/4

Therapy Description

4/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

O Índice de Fragilidade é uma ferramenta que auxilia na interpretação de achados significativos, fornecendo uma medida de força para um resultado. O Índice de Fragilidade representa o número de eventos consecutivos que precisam de ser adicionados a um resultado dicotómico para que o resultado deixe de ser significativo. Um número pequeno representa um resultado mais fraco e um número grande representa um resultado mais forte.

Porque é que este estudo era necessário agora?

Postoperative blood loss following total knee arthroplasty (TKA) may be associated with significant morbidity and impaired functional recovery. There have been many developments in stemming blood loss following surgery, one of which is a topical application of fibrin sealant. While the hemostatic agent has been investigated in prior studies, there is limited evidence of its effect as an adjunct to other blood loss regimens (ie. tranexamic acid, intramedullary femoral canal plugging), as well as its effect on functional recovery.

Qual era a principal questão de investigação?

What is the effect of adjuvant fibrin sealant on postoperative blood loss and early functional recovery following total knee arthroplasty, with blood loss measured within the first 24 postoperative hours and function assessed up to 21 days postoperatively?

Caraterísticas do estudo +
Population:
24 patients (n=48 knees) undergoing simultaneous bilateral total knee arthroplasty. All patients were given preoperative cefuroxime (1.5g intravenously) and tranexamic acid (0.5g 10 min prior to tourniquet inflation (100mmHg above systolic pressure) on the first knee, followed by 0.5g after deflation and before inflation on the second knee), and were operated on with a medial parapatellar approach. Closure of the femoral canal was achieved with an autologous bone plug, and one intra-articular drain (passive) was installed in each knee. Patients either received AGC or Vanguard ROCC (Biomet) prostheses. (Mean age: 65 years)
Intervention:
Fibrin sealant group: After implantation of the knee prosthesis, and while the tourniquet was still inflated, 10mL of fibrin sealant (Evicel) was sprayed onto all instrumented cut surfaces and soft tissues. (n=24 knees)
Comparison:
Control group: After implantation of the knee prosthesis, and while the tourniquet was still inflated, 10mL of saline was sprayed onto all instrumented cut surfaces and soft tissues. (n=24 knees)
Outcomes:
Primary outcome was blood loss within the first 24h postoperatively, measured by drain output. Secondary outcomes included pain on a visual analog scale (VAS), knee swelling measured by knee circumference (1cm proximal to patella), knee range of motion (ROM) using a goniometer, and isometric knee strength.
Methods:
RCT, Double-blind, Placebo-controlled, Single-centre
Time:
Blood loss was measured at 24h postoperatively. Knee pain and swelling were assessed daily until postoperative day (POD) 3, then again at POD 7 and 21. ROM and strength assessment was conducted at POD 3, 7, and 21.
Quais foram os resultados importantes?
  • Mean blood loss calculated from drains at 24h postoperatively was 582mL (SD 328mL) for knees allocated to the fibrin sealant and 576mL (SD 289mL) in knees treated with saline (p=0.9).
  • There was no significant difference in pain between groups either at rest or during flexion at any time-point (all p>0.05).
  • Knee swelling did not significantly differ between groups at any assessment (p>0.05).
  • ROM assessment of both flexion and extension were observed to be similar between groups at each time point, with no significant differences being observed (all P>0.05).
  • Isometric knee strength was similarly reduced from baseline at day 3 assessment in both groups, with gradual recovery. Recovery by day 21 was still lower that preoperative values. There were no significant differences between groups at any of the assessments (all P>0.05).
De que é que me devo lembrar mais?

The use of the fibrin sealant, Evicel, in total knee arthroplasty did not reduce blood loss, nor promote any benefit in functional recovery when compared to placebo treatment with saline in the contralateral knee.

Como é que isto afectará o tratamento dos meus doentes?

The results of the present study do not support the application of adjuvant fibrin sealant as a means to stem postoperative blood loss following total knee arthroplasty. However, there was concern that hyperemia caused by the deflation of the tourniquet may have flushed out the fibrin sealant prior to eliciting any potential effect. It may be worthwhile to determine if there is an effect of Evicel in the absence of tourniquet use.

AVISO LEGAL

O conteúdo desta página destina-se apenas a fins informativos e não pretende substituir o aconselhamento, diagnóstico ou tratamento médico profissional. Se necessitar de tratamento médico, procure sempre o conselho do seu médico ou dirija-se ao serviço de urgência mais próximo. As opiniões, crenças e pontos de vista expressos pelos indivíduos no conteúdo encontrado nesta página não reflectem as opiniões, crenças e pontos de vista da OrthoEvidence.

0 de 4 artigos mensais GRATUITOS desbloqueados
Atingiu o seu limite de 4 visualizações de artigos gratuitos este mês

Aceda à OrthoEvidence por apenas $1,99 por semana.

Mantenha-se ligado às últimas evidências. Cancele a qualquer altura.
  • Avaliações críticas dos mais recentes ensaios clínicos aleatórios de alto impacto e revisões sistemáticas em ortopedia
  • Acesso ao conteúdo do podcast OrthoEvidence, incluindo colaborações com o Journal of Bone and Joint Surgery, entrevistas com cirurgiões reconhecidos internacionalmente e discussões em mesa redonda sobre notícias e tópicos ortopédicos
  • Subscrição do The Pulse, um boletim informativo duas vezes por semana baseado em evidências, concebido para o ajudar a tomar melhores decisões clínicas
Upgrade
Bem-vindo de volta!
Esqueceu-se da palavra-passe?
Comece hoje o seu teste GRATUITO!

A sua conta será afiliada a
e inclui acesso gratuito ao OrthoEvidence


OU
Esqueceu-se da palavra-passe?

OU
Verifique o seu e-mail

Se existir uma conta com o endereço de e-mail fornecido, ser-lhe-á enviado um e-mail de reposição da palavra-passe. Se não vir uma mensagem de correio eletrónico, verifique a sua pasta de spam ou de lixo eletrónico.

Para obter mais assistência, contacte a nossa equipa de apoio.

Inicie sessão para ativar esta funcionalidade

Para aceder a esta funcionalidade, tem de iniciar sessão numa conta OrthoEvidence ativa. Inicie a sessão ou crie uma conta de avaliação GRATUITA.

Traduzir o Relatório ACE

A OrthoEvidence utiliza um serviço de tradução de terceiros para tornar o conteúdo acessível em vários idiomas. Tenha em atenção que, embora sejam feitos todos os esforços para garantir a exatidão, as traduções podem nem sempre ser perfeitas.

Como citar isto ACE Report

OrthoEvidence. TKA: No effect of fibrin sealant on reducing blood loss and functional recovery. OE Journal. 2013;1(8):6. Available from: https://myorthoevidence.com/AceReport/Show/tka-no-effect-of-fibrin-sealant-on-reducing-blood-loss-and-functional-recovery

Copie a citação
Inicie sessão para ativar esta funcionalidade

Para aceder a esta funcionalidade, tem de iniciar sessão numa conta OrthoEvidence ativa. Inicie a sessão ou crie uma conta de avaliação GRATUITA.

Funcionalidade de Membro Premium

Para aceder a esta funcionalidade, tem de ter sessão iniciada numa conta Premium da OrthoEvidence.

Partilhe isto ACE Report